A comprehensive congress fully devoted to clinical debates and controversial issues in a wide range of topics in Bone, Muscle and Joint Diseases including Osteoporosis, Osteoarthritis and Rheumatoid Arthritis
CongressMed is proud to announce the 2nd World Congress on Controversies, Debates and Consensus in Bone, Muscle and Joint Diseases (BMJD), which will take place November 21 – 24, 2013 in Brussels, Belgium.
About the Congress
Over the years, the fields of bone, muscle & joint diseases has undergone enormous expansion in clinical and basic data, as well as that of field-related technology. With the problem of bone, muscle & joint diseases reaching epidemiological dimensions, treatment possibilities have digressed diversely. This development has created a need for debates and discussions on the numerous controversial issues, and to attain clinical conclusions.
The 2nd edition of BMJD aims to continue facilitating effective debate on unresolved clinical and therapeutic dilemmas, supported by evidence-based medicine and expert opinions resulting in agreement on timely issues. The program provides an effective forum for discussing and debating such unresolved controversies, by allowing ample time for speaker-audience discussions with world authorities in the fields of Osteoporosis, Osteoarthritis, Rheumatoid Arthritis, Muscles and Joint Diseases.
The Congress is intended for all members of the medical profession including Endocrinologists, Rheumatologists, Gynecologists, Internal Medicine, Radiologists, Rehabilitation specialists, Public Health professionals, Nurses and Industry Representatives.
- The FRAX index
- Cancer, bones and OP drugs
- Bone metastasis
- Biophospherates: Switching drugs and fracture healing
- Early post menopausal osteoporosis
- Late post menopausal osteoporosis
- What role do biomarkers play in patient selection of optimal intervention
- Cartilage homeostasis and degeneration
- Pain disorders
- New treatments in BMJD
- Cathesin K
- Anabolic treatments and/or uncoupling of bone resorption and bone formation
- To remove or not to remove implants once the fracture has healed
- Biomaterials and cell therapy in cartilage repair
- Neuromuscular control in OA patients
- New targets from proteomic and metabolomic to treat OA
- Diet, nutrition and nutraceuticals in OA management
- Musco-skeletal pain (fibromyalgia, back ache, knee pain .…)
Serono Symposia International Foundation (www.seronosymposia.org) will submit the main congress program of the 2nd World Congress on Controversies, Debates and Consensus in Bone, Muscle and Joint Diseases (BMJD), Brussels, Belgium, November 21 – 24, 2013, for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME).
For the Italian participants
This program of the 2nd World Congress on Controversies, Debates and Consensus in Bone, Muscle and Joint Diseases (BMJD), Brussels, Belgium, November 21 – 24, 2013, will be submitted for CME accreditation from the Italian Ministry of Health.
The CME accreditation is valid for the main congress program only and does not cover the company-sponsored symposia.
ISO 9001 Certification
Serono Symposia International Foundation has received the ISO 9001 Certification of Quality Management Systems. This Quality certification requires all participants to fill in a scientific questionnaire and to evaluate the overall quality of the event. Questionnaires will be distributed onsite during the congress.
CME for USA participants
UEMS/EACCME CME credit recognition
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Under the terms of this agreement, the AMA will convert CME credit certified by the European Accreditation Council for Continuing Medical Education (EACCME), the accrediting arm of the UEMS, to AMA PRA Category 1 Credit™. Physicians (MDs, DOs or equivalent international degree) may have their EACCME credit converted to AMA PRA Category 1 Credit™ by applying to the AMA.